Recent Articles

Can juicing help you get more fruits and vegetables?

How to protect your health in a power outage

Kinesio taping offers only modest relief for musculoskeletal disorders

Scoliosis treatment: Can it help as you get older?

Physical therapy provides modest improvement for chronic low back pain

New resistance training guidance may simplify your workout

What factors speed up aging?

The problem with "classic" Lyme disease symptoms

Is MRI contrast dye safe?

Are those body aches a sign of gallstones?

For "bad" cholesterol, lower is better; dual drug therapy may help

High cholesterol, in particular high low-density lipoprotein (LDL), the so-called bad cholesterol, is a key cause of heart disease. A large clinical trial called IMPROVE-IT set out in 2005 to answer two key questions about LDL:

How low should drug therapy drive LDL?
Can drugs other than statins, the gold standard for lowering cholesterol, help?

The results of IMPROVE-IT were recently published in The New England Journal of Medicine.

Dr. Deepak L. Bhatt, Editor in Chief of the Harvard Heart Letter, talked about the significance of the IMPROVE-IT findings with Dr. Christopher P. Cannon, the trial's lead investigator, and Dr. John A. Jarcho, an editor of The New England Journal of Medicine.

Print This Page

Disclaimer:

As a service to our readers, Harvard Health Publishing provides access to our library of archived content. Please note the date of last review or update on all articles.

No content on this site, regardless of date, should ever be used as a substitute for direct medical advice from your doctor or other qualified clinician.